0000899243-21-034517.txt : 20210830 0000899243-21-034517.hdr.sgml : 20210830 20210830163117 ACCESSION NUMBER: 0000899243-21-034517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210826 FILED AS OF DATE: 20210830 DATE AS OF CHANGE: 20210830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dayno Jeffrey M. CENTRAL INDEX KEY: 0001615993 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 211223932 MAIL ADDRESS: STREET 1: 460 EAST SWEDESFORD ROAD STREET 2: SUITE 1050 CITY: WAYNE STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-26 0 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001615993 Dayno Jeffrey M. 630 W. GERMANTOWN PIKE, SUITE 215215 PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Medical Officer Common Stock 2021-08-26 4 M 0 2159 8.22 A 2159 D Common Stock 2021-08-26 4 S 0 2159 35.0075 D 0 D Common Stock 2021-08-27 4 M 0 7841 8.22 A 7841 D Common Stock 2021-08-27 4 S 0 7841 35.1614 D 0 D Stock Option 8.22 2021-08-26 4 M 0 2159 0.00 D 2027-11-13 Common Stock 2159 91310 D Stock Option 8.22 2021-08-27 4 M 0 7841 0.00 D 2027-11-13 Common Stock 7841 83469 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.43. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021. /s/ Christian Ulrich, Attorney-in-fact 2021-08-30